Enhanced systemic oxidative stress response in patients with idiopathic inflammatory myopathies
Authors:
- Anna Mikołajczyk-KoronaAMAnna Mikołajczyk-Korona
- Radosław DziedzicRadosław Dziedzic
- Krzysztof WójcikKWKrzysztof Wójcik
- Magdalena OlchawaMOMagdalena Olchawa
- Tadeusz SarnaTadeusz Sarna
- Jakub PiętaJPJakub Pięta
- Bogdan JakielaBJBogdan Jakiela
- Lech ZarębaLZLech Zaręba
- Jan G. BazanJBJan G. Bazan
- Daniel P. PotaczekDaniel P. Potaczek
- Joanna Kosałka-WęgielJKJoanna Kosałka-Węgiel
Open Access
- 7 March 2025
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 27 (1) , 1-13
Abstract
Idiopathic inflammatory myopathies (IIM) are characterized by chronic inflammation, endothelial dysfunction, and muscle tissue mitochondrial defect, leading to the local oxidative stress response. However, data on its systemic intensity and correlation with IIM clinical and laboratory characteristics remains scarce. In clinically stable dermatomyositis (n = 18) and myositis (n = 38) patients and matched controls (n = 50), we measured global oxidative stress response in peripheral blood using a novel coumarin boronic acid (CBA) assay enabling real-time detection of protein hydroperoxides (HP) formed in serum. We documented 36% faster kinetics (p < 0.001) and a 68% increase in the cumulative (p = 0.003) fluorescent product generation in the IIM group compared to the control, which indicates higher HP formation associated with systemic oxidative stress. The dynamics of fluorescent product growth were similar in the dermatomyositis and myositis groups. Interestingly, myositis patients with a marked increase in HP formation were characterized by lower serum myoglobin levels (p = 0.038). There was also an inverse correlation between serum myoglobin and the kinetics of HP formation (e.g., for cumulative in-time generation r = –0.35, p = 0.03). The systemic oxidative stress response measures were not related to clinical characteristics of the disease and treatment, internal medicine comorbidities, smoking status, or autoantibody profile. IIM are characterized by a global pro-oxidant imbalance reflected by enhanced HP generation in serum. Furthermore, muscle weakening without active signs of muscle damage may be related to the increased local and systemic oxidative stress response, suggesting non-inflammatory pathomechanism of the disease that our technically undemanding assay may evaluate.Keywords
This publication has 45 references indexed in Scilit:
- A network of core and subtype-specific gene expression programs in myositisActa Neuropathologica, 2021
- Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific AutoantibodiesJAMA Neurology, 2018
- Idiopathic inflammatory myopathies2014
- Dermatomyositis and Type 1 InterferonsCurrent Rheumatology Reports, 2010
- Pathogenesis of idiopathic inflammatory myopathiesCurrent Rheumatology Reports, 2006
- International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathiesArthritis & Rheumatism, 2005
- Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunctionArthritis & Rheumatism, 2005
- Cell Death and Oxidative Damage in Inflammatory MyopathiesClinical Immunology and Immunopathology, 1998
- High endothelial venules (HEVs): specialized endothelium for lymphocyte migrationImmunology Today, 1995
- [2] Thiol/disulfide exchange equilibria and disulfidebond stability1995